EU Annex 11
What is EU Annex 11?
EU Annex 11 is a supplementary guideline to the EU Good Manufacturing Practice (GMP) Guide. It provides specific requirements for computerized systems used in the manufacture of medicinal products, including electronic data processing, storage, and retrieval systems.
What are the key requirements of EU Annex 11?
Key requirements include:
Risk assessment and validation of computerized systems
Ensuring data integrity and security
Establishing appropriate change and incident management procedures
Defining roles and responsibilities for personnel involved in the management of computerized systems
Maintaining appropriate documentation and records related to computerized systems.
What is the scope of Annex 11?
Annex 11 applies to all computerized systems used in the manufacture of medicinal products, including those used for:
Batch release
Stability testing
Regulatory submissions
Complaints handling
Adverse event reporting
How can pharmaceutical companies ensure compliance with Annex 11?
To ensure compliance with Annex 11, pharmaceutical companies should:
Conduct thorough risk assessments of their computerized systems
Implement appropriate validation protocols and documentation
Establish robust data integrity controls and security measures
Provide training to personnel on the proper use and management of computerized systems
Regularly review and update their computerized systems to address changes in regulations and best practices
